Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Tumor Necrosis Factor Drugs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00135720
What this trial is testing

Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Massachusetts General Hospital 12
Large-scale testing (Phase 3)Ended earlyNCT01230827
What this trial is testing

The Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Who this might be right for
Juvenile Idiopathic Arthritis
Janssen Research & Development, LLC 173
Not applicableLooking for participantsNCT07198113
What this trial is testing

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Who this might be right for
Ulcerative Colitis, PediatricInflammatory Bowel DiseasesCrohn Disease
University of North Carolina, Chapel Hill 1,100
Not applicableStudy completedNCT02508012
What this trial is testing

Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases

Who this might be right for
Crohn's DiseaseUlcerative Colitis
University Hospital, Montpellier 260